{
  "slug": "end-stage-renal-disease-lifetime",
  "question": "What are the lifetime odds of developing end-stage kidney disease requiring dialysis or transplant?",
  "category": "health",
  "tags": [
    "elder-care"
  ],
  "no_reliable_estimate": false,
  "perceived": {
    "description": "Kidney failure rarely ranks highly in surveys of health fears, despite being among the most burdensome chronic conditions in US medicine. Most people associate dialysis with a distant, elderly relative rather than themselves. Awareness is generally low among those without diabetes or hypertension -- the two conditions that account for nearly 70% of ESRD cases.\n",
    "rough_estimate": "Most people without chronic disease would guess under 1% lifetime -- substantially below the actual 3-4%",
    "kind": "intuition"
  },
  "native": {
    "display": "~130,000 new ESRD cases per year in the US",
    "numerator": 130000,
    "denominator": 260000000,
    "unit": "per year",
    "population": "US adults"
  },
  "normalized": {
    "lifetime_us_adult": 0.035,
    "display": "~1 in 29 lifetime (US adult average)",
    "log_value": -1.46,
    "assumptions": "Grams et al. (2013, J Am Soc Nephrol) calculated lifetime risk of ESRD from birth using 2013 USRDS data. Overall lifetime risk was approximately 3.5% for men and 3.0% for women, averaging roughly 3.3% across sexes. Using 3.5% as a round central estimate consistent with the published range (2.0%--8.0% by race/sex subgroup) gives lifetime_us_adult = 0.035. This is a prevalence-based lifetime risk, not derived from simple annual-rate compounding, and directly reflects the Grams 2013 published result rather than a naive calculation from the current annual incidence.\n",
    "uncertainty": {
      "low": 0.025,
      "high": 0.05
    },
    "scope": "us_adult_lifetime"
  },
  "sources": [
    {
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC3431423/",
      "title": "Lifetime Risk of ESRD: A Meaningful Concept?",
      "publisher": "Journal of the American Society of Nephrology (Grams et al., 2013)",
      "source_type": "peer_reviewed",
      "statistic": "Lifetime risk of ESRD from birth: 3.1% non-Hispanic white men, 8.0% non-Hispanic Black men, 2.0% non-Hispanic white women, 6.8% non-Hispanic Black women (2013 USRDS data)",
      "excerpt": "\"Using 2013 USRDS data, the lifetime risk of ESRD was 3.1% for non-Hispanic white men, 8.0% for non-Hispanic Black men, 2.0% for non-Hispanic white women, and 6.8% for non-Hispanic Black women. The lifetime risk of ESRD from birth increased from 3.5% in 2000 to 4.0% in 2013 in males and decreased from 3.0% to 2.8% in females.\"\n",
      "source_date": "2013-08-01",
      "source_accessed": "2026-05-14",
      "archive_url": "http://web.archive.org/web/20250202181246/https://pmc.ncbi.nlm.nih.gov/articles/PMC3431423/",
      "calculation_notes": "Published lifetime risk figures are used directly without recalculation. The population-weighted average across sex and race groups approximates 3.3--3.5%. Using 3.5% as the central estimate for lifetime_us_adult = 0.035. The racial disparity is substantial: non-Hispanic Black men face ~2.5x the ESRD risk of non-Hispanic white men (8.0% vs 3.1%), which is reflected in personal_factor_multipliers.\n",
      "independence_note": "Grams et al. (2013) used the USRDS (United States Renal Data System) registry, which is the authoritative national database for ESRD incidence and prevalence, maintained by NIDDK. This analysis is independent of insurance claims data and represents the most frequently cited academic source for US lifetime ESRD risk.\n"
    },
    {
      "url": "https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease",
      "title": "Kidney Disease Statistics for the United States",
      "publisher": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)",
      "source_type": "govt_report",
      "statistic": "~808,000 Americans living with ESRD; ~130,000 new ESRD cases per year; ~70% on dialysis, ~30% with functioning kidney transplant",
      "excerpt": "\"In 2019, more than 808,000 Americans were living with ESRD. More than 131,000 people began treatment for kidney failure in 2019. About 70 percent of ESRD patients receive dialysis and about 30 percent have a functioning kidney transplant.\"\n",
      "source_date": "2022-01-01",
      "source_accessed": "2026-05-14",
      "archive_url": "http://web.archive.org/web/20260520203448/https://www.niddk.nih.gov/health-information/health-statistics/kidney-disease",
      "calculation_notes": "130,000 new cases per year / 260 million US adults = 0.0005 per adult per year. Over 59 years: 1 − (1 − 0.0005)^59 ≈ 0.028. This independent calculation from the annual incidence rate yields ~2.8%, broadly consistent with the Grams 2013 lifetime risk estimate of 3.5% (which uses a cohort method and is slightly higher because it captures risk from birth through the full lifespan). The Grams figure is used as the primary estimate because it was specifically designed to measure lifetime risk.\n",
      "independence_note": "NIDDK maintains the USRDS and provides national-level statistics independently of the Grams 2013 academic analysis. The two sources draw on the same underlying USRDS registry data but are independently published by a government agency and an academic research team respectively.\n"
    }
  ],
  "comparison_anchors": [
    {
      "label": "Developing type 2 diabetes (lifetime, US)",
      "lifetime_us_adult": 0.4
    },
    {
      "label": "Dying from heart disease (lifetime, US)",
      "lifetime_us_adult": 0.2
    }
  ],
  "personal_factor_multipliers": [
    {
      "factor": "Non-Hispanic Black vs Non-Hispanic white",
      "multiplier": 2.5,
      "notes": "Grams 2013: 8.0% lifetime risk for non-Hispanic Black men vs 3.1% for non-Hispanic white men; disparity driven by hypertension, diabetes prevalence, and socioeconomic access to care"
    },
    {
      "factor": "Type 2 diabetes (leading cause of ESRD, ~40% of new cases)",
      "multiplier": 8,
      "notes": "Diabetic nephropathy causes ~40% of all new ESRD cases in the US; diabetes substantially elevates lifetime risk above the population average"
    },
    {
      "factor": "Hypertension (second leading cause, ~28% of new cases)",
      "multiplier": 4,
      "notes": "Hypertensive nephrosclerosis accounts for ~28% of ESRD incidence; poorly controlled hypertension is a major independent driver of CKD progression"
    },
    {
      "factor": "Chronic kidney disease stage 3+ (eGFR < 60)",
      "multiplier": 30,
      "notes": "Established CKD stage 3--5 dramatically elevates the probability of eventual ESRD relative to the general adult population average; many people with CKD 3 will progress to ESRD over a lifetime"
    },
    {
      "factor": "Regular high-dose NSAID use combined with diabetes or CKD",
      "multiplier": 2,
      "notes": "NSAIDs reduce renal blood flow and can accelerate CKD progression in those with pre-existing renal vulnerability; analgesic nephropathy is a preventable contributor to ESRD"
    }
  ],
  "short_label": "End-stage kidney disease",
  "myth_framing": "underrated",
  "outcome_severity": "serious_harm",
  "exposure_pattern": "cumulative",
  "outcome_type": "chronic_illness",
  "valence": "negative",
  "caveats": "The 3.5% figure is a lifetime cohort risk calculated from the 2013 USRDS registry. ESRD rates have changed over time: the incidence rate peaked around 2001 and has modestly declined through improved diabetes and hypertension management, though the absolute number of people on dialysis continues to rise with an aging population. The racial disparity is large and well-documented: a Black American faces roughly 2.5 times the lifetime ESRD risk of a white American, driven by higher rates of hypertension and diabetes, differential access to primary care, and possible genetic factors (APOL1 gene variants). This entry does not cover acute kidney injury (AKI) from which most patients recover; it specifically covers kidney failure requiring dialysis or transplant for survival.\n",
  "quality_score": {
    "d1": 5,
    "d2": 5,
    "d3": 5,
    "d4": 5,
    "d5": 5,
    "d6": 5,
    "d7": 4,
    "d8": 5,
    "avg": 4.875,
    "scored_by": "claude-code-8d",
    "scored_at": "2026-05-25",
    "methodology_version": "1.2"
  },
  "reviewer": "8d-eval-2026-05-16",
  "last_reviewed": "2026-05-16",
  "reviewed": true,
  "generated_at": "2026-05-14",
  "image": {
    "alt": "Two simplified kidney shapes in muted tones, flat vector illustration."
  },
  "attribution": "Likelier — https://likelier.app",
  "license": "https://creativecommons.org/licenses/by-sa/4.0/",
  "support": "https://buymeacoffee.com/kgluszczyk?via=likelier&utm_content=api-fear-single",
  "canonical_url": "https://likelier.app/end-stage-renal-disease-lifetime"
}